5 Pharmaceutical Stocks to Buy According to Efrem Kamen’s Pura Vida Investments

Page 5 of 5

1. ViewRay, Inc. (NASDAQ:VRAY)

Number of Hedge Fund Holders: 17

ViewRay, Inc. (NASDAQ:VRAY) is the largest pharmaceutical stock holding of Efrem Kamen’s Pura Vida Investments, according to 13F filings tracked by Insider Monkey. The demand for its products continues to grow at a hefty pace. The company received seven new orders totaling $39.4 million for its MRIdian systems, bringing the total backlog to $295.1 million as of September from $238.9 million in the previous year period.

ViewRay, Inc. (NASDAQ:VRAY) was in 17 hedge funds’ portfolios as of September. Hudson Executive Capital and Millennium Management were among the leading stakeholders in the company. 

You can also take a look at 10 Pharmaceutical Stocks to Buy Under $20 According to Jeremy Green’s Redmile Group and 10 Dividend Stocks to Buy According to Hoon Kim’s Quantinno Capital.

Page 5 of 5